Author Title [ Type(Desc)] Year
Filters: Author is Tamai, Katsuto  [Clear All Filters]
Journal Article
Kido T, Miyagawa S, Goto T, Tamai K, Ueno T, Toda K, Kuratani T, Sawa Y. The administration of high-mobility group box 1 fragment prevents deterioration of cardiac performance by enhancement of bone marrow mesenchymal stem cell homing in the delta-sarcoglycan-deficient hamster. PLoS One. 2018;13(12):e0202838.
Goto T, Miyagawa S, Tamai K, Matsuura R, Kido T, Kuratani T, Shimamura K, Sakaniwa R, Harada A, Sawa Y. High-mobility group box 1 fragment suppresses adverse post-infarction remodeling by recruiting PDGFRα-positive bone marrow cells. PLoS One. 2020;15(4):e0230392.
Takahashi K, Endo M, Miyoshi T, Tsuritani M, Shimazu Y, Hosoda H, Saga K, Tamai K, Flake AW, Yoshimatsu J, et al. Immune Tolerance Induction Using Fetal Directed Placental Injection in Rodent Models: A Murine Model. PLoS One. 2015;10(4):e0123712.
Ho Y-T, Shimbo T, Wijaya E, Kitayama T, Takaki S, Ikegami K, Miyashita K, Ouchi Y, Takaki E, Yamamoto R, et al. Longitudinal single cell transcriptomics reveals a role for Serpina3n-mediated resolution of inflammation in a mouse colitis model. Cell Mol Gastroenterol Hepatol. 2021.
Ishii Y, Tsuchiya A, Natsui K, Koseki Y, Takeda N, Tomiyoshi K, Yamazaki F, Yoshida Y, Shimbo T, Tamai K, et al. Synthesized HMGB1 peptide prevents the progression of inflammation, steatosis, fibrosis, and tumor occurrence in a nonalcoholic steatohepatitis mouse model. Hepatol Res. 2022.